Yes, External Beam Radiotherapy (XRT) Causes Prostatic and Bulbomembranous Urethral Strictures
External beam radiotherapy for prostate cancer definitively causes urethral strictures, occurring in approximately 1.5% of patients after EBRT alone, with the bulbomembranous region being the most commonly affected site. 1
Incidence and Risk Stratification
The overall prevalence of radiation-induced urethral strictures is 2.2% across all radiation modalities at median 4-year follow-up 1. However, risk varies significantly by treatment approach:
- EBRT alone: 1.5% stricture rate
- Brachytherapy alone: 1.9% stricture rate
- Combined EBRT + brachytherapy: 4.9% stricture rate (3% absolute increase compared to EBRT alone, p=0.018) 1
The combination of EBRT and brachytherapy more than triples the risk of stricture formation compared to EBRT alone, making this the highest-risk scenario 1.
Anatomic Location and Timing
Radiation-induced strictures characteristically occur in the bulbomembranous urethra 2, 3. The median time to stricture development is 2.2 years (range 1.4-9 years), though longer follow-up significantly increases detection rates (p=0.04) 1. This means the true long-term incidence is likely underestimated in most studies.
Mechanism and Dosimetric Risk Factors
Radiation causes strictures through:
- Compromised vascular supply to urethral tissue
- Poor wound healing capacity in irradiated tissue
- Direct radiation damage to the urethral mucosa 2, 4
Specific dosimetric parameters that increase stricture risk include 5:
- Larger planning target volume (PTV) size
- Higher D2cc within 10mm of prostatic urethra (hot spots near the urethra)
- Craniocaudal catheter movement creating unintended high-dose areas in the bulbomembranous urethra
Critical Clinical Pitfall
Performing bladder outlet obstruction procedures (BOOP) AFTER radiotherapy dramatically increases genitourinary toxicity compared to performing them BEFORE radiation. Men undergoing resective surgery after XRT face significantly elevated risks of 6:
- Stress urinary incontinence (RR 4.29)
- Urethral strictures (RR 3.28)
- Bladder neck contracture (RR 2.56)
- Urinary retention (RR 2.38)
Therefore, evaluate and treat concomitant benign prostatic hyperplasia BEFORE initiating radiotherapy whenever possible 6.
Management Implications
When strictures do develop, they are challenging to treat due to the compromised tissue quality. Urethroplasty with excision and primary anastomosis achieves 73% success rates at 21 months, but carries a 40% risk of persistent incontinence and 50% erectile dysfunction 2. The proximity to the sphincter mechanism makes any intervention high-risk for continence.
Patients should be counseled pre-treatment that radiation increases incontinence risk over time (unlike surgery where incontinence improves over time), and that adjuvant radiation cases experience particularly high rates of both stress and urge incontinence 7.